1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Epidemics (including Covid-19, not Long Covid)

Discussion of epidemics including Covid-19

Page 1 of 26
Sort By:
Title Start Date
Replies Views ↑
Last Message
  1. SNT Gatchaman

    Mast cell activation triggered by SARS-CoV-2 causes inflammation in brain microvascular endothelial cells and microglia, 2024, Wu et al.

    SNT Gatchaman, Apr 19, 2024 at 11:19 PM
    Replies:
    0
    Views:
    46
    SNT Gatchaman
    Apr 19, 2024 at 11:19 PM
  2. EndME

    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19,

    EndME, Apr 4, 2024
    Replies:
    0
    Views:
    144
    EndME
    Apr 4, 2024
  3. SNT Gatchaman

    Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity, 2024, Okazaki et al.

    SNT Gatchaman, Mar 29, 2024
    Replies:
    0
    Views:
    147
    SNT Gatchaman
    Mar 29, 2024
  4. Mij

    ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection, 2024, Tianhao Duan et al

    Mij, Mar 29, 2024
    Replies:
    7
    Views:
    164
    Mij
    Mar 29, 2024
  5. ahimsa

    USA - Marketplace (radio): Protecting yourself from COVID-19 these days is hard. And it comes at a cost.

    ahimsa, Mar 23, 2024
    Replies:
    0
    Views:
    191
    ahimsa
    Mar 23, 2024
  6. Mij

    Early tx with fluvoxamine, bromhexine, cyproheptadine and niclosamide to prevent clinical deterioration in pts with Covid-19. . .clinical trial, 2024

    Mij, Mar 15, 2024
    Replies:
    2
    Views:
    200
    EndME
    Mar 15, 2024
  7. Mij

    Screening Commercial Tea for Rapid Inactivation of Infectious SARS-CoV-2 in Saliva

    Mij, Apr 8, 2024
    Replies:
    4
    Views:
    212
    Mij
    Apr 9, 2024
  8. Mij

    Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19, 2024, Daisuke Kasugai et al

    Mij, Mar 11, 2024
    Replies:
    0
    Views:
    240
    Mij
    Mar 11, 2024
  9. SNT Gatchaman

    ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients, 2024, Song et al.

    SNT Gatchaman, Mar 27, 2024
    Replies:
    3
    Views:
    245
    Jonathan Edwards
    Mar 28, 2024
  10. Mij

    The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs

    Mij, Sep 29, 2023
    Replies:
    0
    Views:
    253
    Mij
    Sep 29, 2023
  11. SNT Gatchaman

    Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein, 2023, Bamberger et al.

    SNT Gatchaman, Nov 9, 2023
    Replies:
    0
    Views:
    253
    SNT Gatchaman
    Nov 9, 2023
  12. Sly Saint

    NHS rolls out new variant Covid vaccine as virus continues to kill 100 a week

    Sly Saint, Apr 17, 2024 at 4:39 PM
    Replies:
    5
    Views:
    257
    Arnie Pye
    Apr 17, 2024 at 6:15 PM
  13. Mij

    Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications, 2023, Colin R. Dormuth

    Mij, Oct 2, 2023
    Replies:
    0
    Views:
    260
    Mij
    Oct 2, 2023
  14. Dakota15

    USA - NIH: Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins, Sept 2023

    Dakota15, Sep 24, 2023
    Replies:
    0
    Views:
    261
    Dakota15
    Sep 24, 2023
  15. Andy

    Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients 2023 Moatar et al

    Andy, Aug 24, 2023
    Replies:
    0
    Views:
    262
    Andy
    Aug 24, 2023
  16. EndME

    Dissecting human population variation in single-cell responses to SARS-CoV-2, 2023, Quintana-Murci et al

    EndME, Aug 31, 2023
    Replies:
    0
    Views:
    263
    EndME
    Aug 31, 2023
  17. Andy

    Long-term comprehensive cardiopulmonary phenotyping of COVID-19, 2022, Kimmig et al

    Andy, Sep 22, 2022
    Replies:
    0
    Views:
    266
    Andy
    Sep 22, 2022
  18. EndME

    Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor, 2023, Chia et al

    EndME, Jul 31, 2023
    Replies:
    0
    Views:
    266
    EndME
    Jul 31, 2023
  19. EndME

    SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency, 2023, Li et al

    EndME, Sep 11, 2023
    Replies:
    0
    Views:
    270
    EndME
    Sep 11, 2023
  20. Mij

    Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir, 2023, Yinkai Duan et al

    Mij, Sep 11, 2023
    Replies:
    0
    Views:
    270
    Mij
    Sep 11, 2023
Showing threads 1 to 20 of 507

Thread Display Options

Loading...
Page 1 of 26